Bayer Healthcare Pharmaceuticals - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

 Published On: Dec, 2017 |    No of Pages: 247 |  Published By: MarketLine | Format: PDF
Request Free Sample

Summary

Marketline's Bayer Healthcare Pharmaceuticals Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Bayer Healthcare Pharmaceuticals since January2007.

Synopsis

Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Bayer Healthcare Pharmaceuticals's contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Bayer Healthcare Pharmaceuticals. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Bayer Healthcare Pharmaceuticals's M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Bayer Healthcare Pharmaceuticals and its subsidiaries since 2007.
- Information about key financial and legal advisors for Bayer Healthcare Pharmaceuticals's financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Bayer Healthcare Pharmaceuticals’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 4
LIST OF TABLES 5
LIST OF FIGURES 5
TARGETS AND PARTNERS 6
MERGERS & ACQUISITIONS 7
Mergers and Acquisitions – Deal reports 7
PARTNERSHIP 10
Partnership – Overview 10
Partnership – Deal reports 11
APPENDIX 237
Contact Us 237
About MarketLine Financial Deals Database 237
Deal Definition and Methodology 239
About MarketLine 246

List of Tables
Table 1: Bayer Healthcare Pharmaceuticals partnership volume and value trend (2013-YTD2017)
Table 2: Bayer Healthcare Pharmaceuticals partnership trend by key deal type (2013-YTD2017)

List of Figures
Figure 1: Bayer Healthcare Pharmaceuticals partnership volume and value trend (2013-YTD2017)
Figure 2: Bayer Healthcare Pharmaceuticals partnership trend by key deal type (2013-YTD2017)


If the above report does not have the information suitable for your business, we can provide custom research that can be lucrative for your business or enhance your profession.